WeVote
Log In

Bill

Bill

HB 2209

Relating to controlled substance monitoring; and removing a dispensing prohibition

2025 Regular Session Introduced by Brandon Steele

HB 2209 streamlines opioid antagonist reporting and lifts a dispensing ban, improving patient access to medications while maintaining essential oversight on controlled substances.

To House Health and Human Resources
#health
0
WeVote Research Nonpartisan
Bill Summary · HB 2209

Summary of House Bill 2209 (HB 2209)

Overview

House Bill 2209 (HB 2209) is a legislative proposal introduced in the West Virginia Legislature aimed at amending the state's controlled substance monitoring laws. The bill seeks to remove certain reporting requirements related to opioid antagonists and to eliminate a dispensing prohibition associated with controlled substances.

Purpose and Intent

The primary purpose of HB 2209 is to streamline the reporting process for controlled substances and opioid antagonists within the Controlled Substances Monitoring Program (CSMP) Database. By removing unnecessary reporting requirements, the bill aims to facilitate better access to these medications while maintaining oversight to prevent misuse.

Key Provisions

The bill includes several significant changes to existing law:

  1. Reporting Requirements:

    • Removal of Reporting for Opioid Antagonists: The bill proposes to eliminate the requirement for medical service providers to report the dispensing of opioid antagonists to the CSMP Database.
    • Controlled Substances Reporting: It retains the requirement for medical service providers to report the dispensing of controlled substances listed in Schedules II, III, IV, and V, including details such as:
      • Name and address of the dispensing pharmacy or practitioner.
      • Patient's full legal name, address, and birth date.
      • Details of the controlled substance dispensed (name, dosage, quantity).
      • Dates of prescription writing and filling.
      • Information about the person picking up the prescription if not the patient.

  2. Overdose Reporting:

    • Medical service providers are required to report information regarding patients treated for overdoses resulting from illicit or prescribed medications, including the patient's identity and any relevant evidence.

  3. Dispensing Prohibition:

    • The bill seeks to remove a prohibition on dispensing certain controlled substances, which is intended to enhance access to necessary medications while ensuring proper monitoring.

  4. Coordination with Other Agencies:

    • The Board of Pharmacy will coordinate with the Division of Justice and Community Services and the Office of Drug Control Policy for the collection of overdose data.

Impact

  • Healthcare Providers: The bill is expected to ease the administrative burden on healthcare providers by reducing the number of reporting requirements, particularly for opioid antagonists.
  • Patients: By removing the dispensing prohibition, patients may have improved access to necessary medications, particularly in emergency situations involving overdoses.
  • Regulatory Oversight: The bill maintains essential monitoring of controlled substances, ensuring that while access is improved, the potential for misuse is still addressed.

Legislative Timeline

  • Introduced: February 12, 2025
  • Referred to Health and Human Resources: February 12, 2025
  • First Reading: February 4, 2025
  • Executive Committee Approval: March 12, 2025
  • Second Reading: March 27, 2025
  • Re-referred to Rules Committee: May 31, 2025

Conclusion

HB 2209 represents a significant step towards improving the efficiency of controlled substance monitoring in West Virginia. By removing certain reporting requirements and a dispensing prohibition, the bill aims to enhance access to critical medications while ensuring that monitoring and oversight remain intact.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.